MVA-RSV

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameMVA-RSV

Drug Alias NameMVA-RSV

ClassificationVaccines > Development/production technology > Inactivated vaccineVaccines > Development/production technology > Recombinant vector vaccine

Mechanisms of ActionRespiratory syncytial virus F protein modulators

TargetsRespiratory syncytial virus F protein

Therapy Area/IndicationsRespiratory Syncytial Virus Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesEmergent Biosolutions Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesEmergent Biosolutions Inc

Active IndicationsN/A

Inactive IndicationsRespiratory Syncytial Virus Infections

Other Information

ATC CodeN/A